Ohr Pharmaceutical

+$0.32 (+4.18%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can watch OHRP and buy or sell other stocks, options, and ETFs commission-free!

About OHRP

NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines.

CEO
Dietrich A. Stephan, PhD
Employees
—
Headquarters
Pittsburgh, Pennsylvania
Founded
2009

OHRP Key Statistics

Market cap
32.90M
Price-Earnings ratio
—
Dividend yield
—
Average volume
57.78K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$5.51
52 Week low
$0.89
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure